Shiratori Pharmaceutical
Shiratori Pharmaceutical Co., Ltd., commonly referred to as Shiratori Pharma, is a prominent player in the pharmaceutical industry, headquartered in Japan. Established in the early 20th century, the company has made significant strides in developing innovative healthcare solutions, particularly in the fields of prescription medications and over-the-counter products. With a strong operational presence across Asia, Shiratori Pharma is renowned for its commitment to quality and research-driven approaches. The company’s core offerings include a diverse range of pharmaceuticals that address various health conditions, setting them apart through their focus on efficacy and safety. Recognised for its contributions to healthcare, Shiratori Pharmaceutical has achieved notable milestones, solidifying its market position as a trusted name in the industry. Through continuous innovation and dedication to patient care, Shiratori Pharma remains a key player in advancing health solutions in the region.
DitchCarbon Score
How does Shiratori Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shiratori Pharmaceutical's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shiratori Pharmaceutical's reported carbon emissions
Shiratori Pharmaceutical, headquartered in Japan, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As the industry evolves, it is expected that Shiratori Pharmaceutical will align with these trends and establish measurable climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shiratori Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
